AstraZeneca PLC Stock Price and Value Analysis

Should you buy AstraZeneca PLC stock? (NYSE:AZN). Let's see how it does in our automated value investing analysis system.

  • This company has fluctuating growth.
  • This company has a high dividend yield.
  • This company is less known than others.
  • This company is not making money.
  • This stock looks overpriced.

Inside the AZN Numbers

AZN Price
(AstraZeneca PLC stock price per share)
[?] PE Ratio versus Sector 127% higher than other Healthcare stocks
[?] PE Ratio versus Industry 415% higher than other Unknown stocks
[?] Cash Yield 1.56%
[?] Free Cash Flow Jitter 28%
[?] Dividend Yield 3%
Shares Shorted 5,760,994

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 5,760,994 shares shorted. With 3,087,745,620 shares available for purchase and an average trading volume over the past 10 trading days of 4,427,420, it would take at least 1.301 days for all of the short holders to cover their shorts.

Is AstraZeneca PLC Stock on Sale?

Based on our analysis, we believe that you should not buy AstraZeneca PLC right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy AZN Stock?

Does AstraZeneca PLC have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.